Name | 7-Methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4(3H)-one |
Synonyms | Gefitinib iMpurity F Gefitinib Impurity 14 Getitinib interMediate 7-METHOXY-6-(3-MORPHOLINOPROPOXY)QUINAZOLIN-4(3H)-ONE 7-methoxy-6-(3-morpholinopropoxy)quinazolin-4(3h)-one 7-Methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4(3H)-one 7-methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one 7-Methoxy-6-[3-(4-morpholinyl)propoxy]-4(3H)-quinazolinone 7-methoxy-6-[3-(morpholin-4-yl)propoxy]quinazolin-4(1H)-one 7-Methoxy-6-(3-morpholinopropoxy)-3,4-dihydroquinazolin-4-one 7-Methoxy-6-(3-Morpholin-4-ylpropoxy) Quinazolin-4-(3H)-One Gefitinib HCL InterMediates G5 |
CAS | 199327-61-2 |
EINECS | 429-400-7 |
InChI | InChI=1/C16H21N3O4/c1-21-14-10-13-12(16(20)18-11-17-13)9-15(14)23-6-2-3-19-4-7-22-8-5-19/h9-11H,2-8H2,1H3,(H,17,18,20) |
Molecular Formula | C16H21N3O4 |
Molar Mass | 319.36 |
Density | 1.32±0.1 g/cm3(Predicted) |
Melting Point | 233-236 °C |
Boling Point | 519.5±60.0 °C(Predicted) |
Flash Point | 268.002°C |
Solubility | DMSO (Slightly), Methanol (Slightly) |
Vapor Presure | 0mmHg at 25°C |
Appearance | Solid |
Color | White to Off-White |
pKa | 7.10±0.10(Predicted) |
Storage Condition | 2-8°C |
Refractive Index | 1.611 |